- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Friedreich’s ataxia
- Meeting Date: November 2025
- Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 1.1MB)
- Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 675.0KB)
Omaveloxolone – November 2025
Omaveloxolone: Capsule 50 mg; Skyclarys® - November 2025
Last updated
5 November 2025